Each week, we identify one top search term, speculate as to what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, feel free to share them with us on Twitter or Facebook!
Clinical Trend of the Week (May 21-27): Glioblastoma
Glioblastoma brain tumors may have found a new enemy. According to new findings, a novel combination of a cytomegalovirus (CMV)-targeted dendritic cell (DC) vaccine results in significant improvements in overall survival in phase 2 clinical trials. After preconditioning with a tetanus booster, CMV pp65-DC vaccines showed encouraging survival data in a small study. So far, the CMV-targeting vaccine has demonstrated a good safety profile and significant increases in median progression-free survival (25.3 mo) and overall survival (41.1 mo). Physicians looking to provide the best treatment possible to patients who typically have a short clinical history certainly increased searches for this condition this week.
For more information on glioblastoma, read here.
Medscape © 2016
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Clinical Trends for May 2016 - Medscape - May 06, 2016.